Deguan Lv

2.0k total citations
25 papers, 1.1k citations indexed

About

Deguan Lv is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Deguan Lv has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Pharmacology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Deguan Lv's work include Apelin-related biomedical research (11 papers), Nuclear Receptors and Signaling (10 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (9 papers). Deguan Lv is often cited by papers focused on Apelin-related biomedical research (11 papers), Nuclear Receptors and Signaling (10 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (9 papers). Deguan Lv collaborates with scholars based in China, United States and Mexico. Deguan Lv's co-authors include Linxi Chen, Yanxin Li, Weiwei Zhang, Haizhong Feng, Lanfang Li, Jianming Tang, Youzhou Sang, Angel A. Alvarez, Bo Hu and Linxi Chen and has published in prestigious journals such as Nature Communications, Molecular Cell and Cancer Research.

In The Last Decade

Deguan Lv

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deguan Lv China 18 561 344 306 265 225 25 1.1k
Curran Murphy United States 8 594 1.1× 122 0.4× 171 0.6× 241 0.9× 71 0.3× 12 1.2k
Yujung Kang South Korea 14 409 0.7× 209 0.6× 318 1.0× 208 0.8× 145 0.6× 19 935
Junfang Zheng China 21 549 1.0× 78 0.2× 95 0.3× 245 0.9× 75 0.3× 44 886
Alicia Zukas United States 9 170 0.3× 259 0.8× 107 0.3× 99 0.4× 43 0.2× 21 687
Sripriya Ranganathan United States 10 455 0.8× 68 0.2× 76 0.2× 205 0.8× 79 0.4× 13 945
Masafumi Takata Japan 12 760 1.4× 52 0.2× 150 0.5× 74 0.3× 67 0.3× 19 1.1k
Jinsheng Huang China 15 438 0.8× 50 0.1× 72 0.2× 157 0.6× 57 0.3× 43 863
Nagadhara Dronadula United States 16 358 0.6× 51 0.1× 147 0.5× 121 0.5× 35 0.2× 22 643
John Öhd Sweden 16 361 0.6× 223 0.6× 102 0.3× 175 0.7× 42 0.2× 30 883
Janet K. Lighthouse United States 13 465 0.8× 65 0.2× 200 0.7× 195 0.7× 41 0.2× 17 920

Countries citing papers authored by Deguan Lv

Since Specialization
Citations

This map shows the geographic impact of Deguan Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deguan Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deguan Lv more than expected).

Fields of papers citing papers by Deguan Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deguan Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deguan Lv. The network helps show where Deguan Lv may publish in the future.

Co-authorship network of co-authors of Deguan Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Deguan Lv. A scholar is included among the top collaborators of Deguan Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deguan Lv. Deguan Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gimple, Ryan C., Guoxin Zhang, Shuai Wang, et al.. (2023). Sorting nexin 10 sustains PDGF receptor signaling in glioblastoma stem cells via endosomal protein sorting. JCI Insight. 8(6). 10 indexed citations
2.
Lv, Deguan, Cuiqing Zhong, Deobrat Dixit, et al.. (2023). EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma. Molecular Cell. 83(23). 4334–4351.e7. 36 indexed citations
3.
Liu, Ning, Deguan Lv, Hongyan Yang, et al.. (2023). Intracavitary cardiac metastasis of cervical squamous cell carcinoma with immune thrombocytopenia: a rare case report. Frontiers in Oncology. 13. 1239606–1239606. 1 indexed citations
4.
Dixit, Deobrat, Briana C. Prager, Ryan C. Gimple, et al.. (2022). Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterases. Science Translational Medicine. 14(626). eabf3917–eabf3917. 19 indexed citations
5.
Lv, Deguan, Ryan C. Gimple, Cuiqing Zhong, et al.. (2022). PDGF signaling inhibits mitophagy in glioblastoma stem cells through N-methyladenosine. Developmental Cell. 57(12). 1466–1481.e6. 54 indexed citations
6.
Lv, Deguan, Xuling Luo, Zhe Chen, et al.. (2021). Apelin/APJ signaling activates autophagy to promote human lung adenocarcinoma cell migration. Life Sciences. 281. 119763–119763. 9 indexed citations
7.
Wang, Dongrui, Briana C. Prager, Ryan C. Gimple, et al.. (2020). CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies. Cancer Discovery. 11(5). 1192–1211. 121 indexed citations
8.
Liu, Wei, Cuiqing Zhong, Deguan Lv, Mengjie Tang, & Feng Xie. (2020). N6-Methyladenosine RNA Methylation Regulators Have Clinical Prognostic Values in Hepatocellular Carcinoma. Frontiers in Genetics. 11. 863–863. 5 indexed citations
9.
Huang, Shifang, et al.. (2020). Targeting AQP4 localization as a novel therapeutic target in CNS edema. Acta Biochimica et Biophysica Sinica. 53(2). 269–272. 5 indexed citations
10.
Sang, Youzhou, Yanxin Li, Lina Song, et al.. (2018). TRIM59 Promotes Gliomagenesis by Inhibiting TC45 Dephosphorylation of STAT3. Cancer Research. 78(7). 1792–1804. 47 indexed citations
11.
He, Lu, Qionglin Zhou, Zheng Huang, et al.. (2018). PINK1/Parkin‐mediated mitophagy promotes apelin‐13‐induced vascular smooth muscle cell proliferation by AMPKα and exacerbates atherosclerotic lesions. Journal of Cellular Physiology. 234(6). 8668–8682. 105 indexed citations
12.
Lv, Deguan, Jia Feng, Yanli Hou, et al.. (2017). Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding. Cancer Research. 77(22). 6190–6201. 90 indexed citations
13.
Lv, Deguan, Yanxin Li, Weiwei Zhang, et al.. (2017). TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma. Nature Communications. 8(1). 1454–1454. 103 indexed citations
14.
Liu, Xuan, Chao Cao, Dong Han, et al.. (2015). Apelin-13 induces autophagy in hepatoma HepG2 cells through ERK1/2 signaling pathway-dependent upregulation of Beclin1. Oncology Letters. 11(2). 1051–1056. 17 indexed citations
15.
Xie, Feng, Wei Liu, Fen Feng, et al.. (2015). Apelin-13 promotes cardiomyocyte hypertrophy via PI3K-Akt-ERK1/2-p70S6K and PI3K-induced autophagy. Acta Biochimica et Biophysica Sinica. 47(12). 969–980. 55 indexed citations
16.
Lv, Deguan, et al.. (2014). ELABELA: a novel hormone in cardiac development acting as a new endogenous ligand for the APJ receptor. Acta Biochimica et Biophysica Sinica. 46(7). 620–622. 28 indexed citations
17.
Xie, Feng, Wei Liu, Fen Feng, et al.. (2014). A static pressure sensitive receptor APJ promote H9c2 cardiomyocyte hypertrophy via PI3K-autophagy pathway. Acta Biochimica et Biophysica Sinica. 46(8). 699–708. 26 indexed citations
18.
Li, Lifang, Lanfang Li, Zidong Zhang, et al.. (2013). Jagged-1/Notch3 signaling transduction pathway is involved in apelin-13-induced vascular smooth muscle cells proliferation. Acta Biochimica et Biophysica Sinica. 45(10). 875–881. 67 indexed citations
19.
Su, Tao, Deguan Lv, Feng Xie, et al.. (2013). ERK1/2 mediates lung adenocarcinoma cell proliferation and autophagy induced by apelin-13. Acta Biochimica et Biophysica Sinica. 46(2). 100–111. 60 indexed citations
20.
Lv, Deguan, et al.. (2013). Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis. Acta Biochimica et Biophysica Sinica. 45(7). 527–533. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026